These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System. Ryall S; Arnoldo A; Krishnatry R; Mistry M; Khor K; Sheth J; Ling C; Leung S; Zapotocky M; Guerreiro Stucklin A; Lassaletta A; Shago M; Tabori U; Hawkins CE J Neuropathol Exp Neurol; 2017 Jul; 76(7):562-570. PubMed ID: 28863456 [TBL] [Abstract][Full Text] [Related]
24. A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration. Chiang J; Harreld JH; Tinkle CL; Moreira DC; Li X; Acharya S; Qaddoumi I; Ellison DW Acta Neuropathol; 2019 Dec; 138(6):1091-1092. PubMed ID: 31595312 [No Abstract] [Full Text] [Related]
25. A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment. Ryall S; Tabori U; Hawkins C Brain Tumor Pathol; 2017 Apr; 34(2):51-61. PubMed ID: 28342104 [TBL] [Abstract][Full Text] [Related]
26. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review. Thomas DL Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356 [TBL] [Abstract][Full Text] [Related]
27. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Kim YH; Nonoguchi N; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Mariani L; Giangaspero F; Tanaka Y; Nakazato Y; Vital A; Mittelbronn M; Perry A; Ohgaki H Brain Pathol; 2012 Nov; 22(6):834-40. PubMed ID: 22568401 [TBL] [Abstract][Full Text] [Related]
28. Recent Advances on the Molecular Pathology of Glial Neoplasms in Children and Adults. Rodriguez FJ; Vizcaino MA; Lin MT J Mol Diagn; 2016 Sep; 18(5):620-634. PubMed ID: 27444975 [TBL] [Abstract][Full Text] [Related]
29. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. Brayer KJ; Frerich CA; Kang H; Ness SA Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070 [TBL] [Abstract][Full Text] [Related]
30. Pediatric-type diffuse low grade gliomas: Histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification. Purkait S; Mahajan S; Sharma MC; Sarkar C; Suri V Indian J Pathol Microbiol; 2022 May; 65(Supplement):S42-S49. PubMed ID: 35562133 [TBL] [Abstract][Full Text] [Related]
31. Paediatric-type diffuse low-grade gliomas: a clinically and biologically distinct group of tumours with a favourable outcome. Fabbri VP; Caporalini C; Asioli S; Buccoliero A Pathologica; 2022 Dec; 114(6):410-421. PubMed ID: 36534420 [TBL] [Abstract][Full Text] [Related]
32. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients. Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182 [TBL] [Abstract][Full Text] [Related]
33. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294 [TBL] [Abstract][Full Text] [Related]
34. Molecular genetics and therapeutic targets of pediatric low-grade gliomas. Tateishi K; Nakamura T; Yamamoto T Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113 [TBL] [Abstract][Full Text] [Related]
35. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609 [TBL] [Abstract][Full Text] [Related]
36. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors. Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289 [TBL] [Abstract][Full Text] [Related]
37. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors. Patel RR; Ramkissoon SH; Ross J; Weintraub L Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112 [TBL] [Abstract][Full Text] [Related]